forecasting
Clinical Trial Supply 2015 Research
August 17 by Pharma IQ SurveysPharma IQ would like to invite you to take part in this short industry survey. The survey will take less than 10 minutes to complete and as a thank you, all participants who complete the...
The Future of Clinical Trial Supply – Trends and Challenges 2015 Report
October 13 by Pharmaceuticals & Biotechnology EditorIn this report, we gather these responses as well as expert insight on the findings along with interviews with thought leaders and articles on key trends to give you an in depth look at the current st...
IMS Disease Insights – Alzheimer’s disease: Primary research & evidence-based data
November 11 by Pharmaceuticals & Biotechnology EditorOf the nine major pharmaceutical markets (i.e., US, UK, France, Germany, Italy, Spain, Japan, China, Brazil), IMS Health forecasts that the Alzheimer’s disease market will grow from $5.7 billion in 20...
Innovative Therapies for Alzheimer’s Disease
September 26 by Pharmaceuticals & Biotechnology EditorIn the US alone, Alzheimer’s disease healthcare costs are projected to increase from $200 billion in 2013 to $1.2 trillion by 2050. Thus, the lack of good treatment options for AD creates a he...
Top Tips for Ensuring Seamless Integration between Processes and IT Systems
July 14 by Pharma IQPharma IQ caught up with Dr. Wolfgang Schmitt, Business Development Manager Pharma at IDS Scheer, to discuss the challenges which arise when optimising supply chains and how we s...